Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Takeda Outlicenses Two CCR5 Antagonists To Newly Formed Tobira

Aug 03 2007

• By Pamela Taulbee

Related Content

Pfizer’s Maraviroc Deemed “Approvable” By FDA

Jun 21 2007

Schering-Plough, Incyte Report Positive Mid-Stage Data For CCR5 Antagonists

Jul 24 2007

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window